Hogan Lovells recently hosted a 60-minute webinar on FDA's Regulation of Stem Cells and Regenerative Medicine in Light of Regenerative Sciences. The webinar took place on Tuesday, April 1, 2014 at 1:00 p.m. ET and covered the following topics:
- Can stem cell therapies still be considered within the practice of medicine and outside the realm of FDA oversight?
- The implications of Regenerative Sciences with respect to pre- and post-market oversight.
- The effect of growing demand for stem cell treatments and the risks of medical tourism to countries with inadequate regulatory oversight.
- Development models: practical pathways from research to profitability.